Published clinical literature is outside the scope of RUO product positioning and should not be interpreted as use guidance for research-use-only materials
Kimji, MD, FRCPC) reviews clinical statements, safety claims, and contraindication lists before publication
1-3 The 10-year threshold of 20% for high" predicted risk by PREVENT CVD reflects a CVD event rate (2% per year) equivalent to that typically encountered among patients with existing CVD
If side effects persist, your doctor may recommend delaying dose escalation rather than reducing the dose
Influenza, however, develops rapidly over hours to a day or two, peaks in severity, and typically resolves within a week, though fatigue may linger
Patients with a history of mental health disorders should use it under close medical supervision